Abstract: The present invention discloses a new application of a composition of phillyrin and phillygeninin in the preparation of drugs for alleviating or/and treating viral diseases. Experiments prove that the composition of phillyrin and phillygeninin has significant treatment effects on viral influenza and pneumonia, as well as on respiratory syncytial viruses, enteroviruses, herpes zoster simplex viruses, Coxsackie viruses, and the like. This composition is characterized by quick action and less toxic and side effects, and thus is an antiviral drug and health product with safety, high efficiency, stability and simple preparation process, and is suitable for industrial production and easy to promote. The present invention provides a new drug, health product and raw material for preventing and treating various viral diseases.

Abstract: Modified asphalt particles contain asphalt and a modifier. The modifier comprises poly-sulfur and free sulfur. The sulfur element accounts for 10-40 weight percent of the total amount of the modified asphalt particles, and the poly-sulfur accounts for 30-70 weight percent of the total amount of the sulfur element. The total particle size of the modified asphalt particle is smaller than or equal to 150 ?m. The modified asphalt particles have an excellent high temperature performance, and can be used for preparing drilling fluids. Water-in-oil based drilling fluid obtained from the modified asphalt particles has low plastic viscosity, high dynamic shear force, high dynamic plastic ratio, and high emulsion-breaking voltage, and improves the high temperature resistance and cutting carrying capability of a system.

Abstract: The present invention discloses an application of ginsenoside Rg3 in preparing a medicine or product for preventing and treating dementia, and a preparation method thereof, which belong to the fields of medicines and health care products, and its products comprise a topical preparation, oral preparation and injection of the ginsenoside Rg3; and the Rg3 medicine or formulating prepared Rg3 compound medicine is prepared by using a solubilizer, a transdermal agent, a reagent promoting the absorption by penetrating a blood-brain barrier and an extractive, achieving the effect that the medicine penetrates the blood-brain barrier, and is used for preventing and treating dementia.

Abstract: A first communication device determines one or more parameters related to a format of a media access control layer (MAC) data unit for an uplink (UL) multi-user (MU) transmission. The format of the MAC data unit for the UL MU transmission is different than a format of a MAC data unit for an UL single user (SU) transmission. The first communication device generates one or more data units that include the one or more parameters. The first communication device transmits the one or more data units to a plurality of second communication devices to inform the plurality of second communication devices of the format of the MAC data unit for UL MU transmissions by the plurality of second communication devices to the first communication device.

Abstract: Aspects of the disclosure are directed to a circuit. In accordance with one aspect, the circuit includes a first layer, wherein the first layer includes two-dimensional (2D) shapes; a second layer coupled adjacent to the first layer through at least one via hole, wherein the second layer includes only one-dimensional (1D) shapes; a shared drain terminal; and a source terminal termination.

Abstract: The present application describes a composition and method thereof to make low cost environment friendly and highly safe conducive ink by using micro-sized silver particles, water, edible level thickener, water-based solvent, water-based resin and surfactant. The conductive ink may be written by various kinds of writing devices like gel pen, ball pen etc. on various substrates like paper, plastic, metal, etc. form a conductive trace. As additional features of the present application, the composition comprises erasable conductive ink, which is fast curing and conductive immediately upon application, having multiple applications for educational purpose to help students have a better understanding of how electronic work and even design their own electronics conveniently.

Abstract: The invention discloses new application of a ginseng extract, ginsenoside and a ginsenoside derivative in the preparation of a medicine for treating HCMV infection related diseases. The related diseases comprise HCMV infection caused in the process of treating cardiovascular and cerebrovascular diseases, organ transplantation, perinatal periods, tumors, burn, AIDS and other diseases of patients. Tests prove that the ginseng extract, the ginsenoside and the ginsenoside derivative have a remarkable curative effect, quick response and a small toxic or side effect during treatment of HCMV infected diseases, are a medicine or a health product for treating the HCMV infection, which is safe, efficient and stable and has a simple preparation process, and are suitable for industrial production and easy to popularize. In the invention, a new medicine source is provided for the treatment of the HCMV infection.

Abstract: The present invention provides 20(R)-ginsenoside Rg3 polyacylated derivatives of the formula (I) and preparation method and anti-tumor application thereof: wherein, R?CH3(CH2)nCO, n=0˜5.

Abstract: The present invention provides a pharmaceutical compound of phillygenin ibuprofen ester as represented by formula (I), preparation method thereof, and applications thereof in anti-virus, antipyresis, anti-inflammation, analgesia and the like:

Abstract: The present invention provides a novel phillygenin glucuronic acid derivative shown as a general formula (I). wherein, R1?H, R2?CnH2n+1, R3?CnH2n+1 or R1?CnH2n+1, R2?CnH2n+1,R3?H or R1-R2?—CH2-, —, R3?CnH2n+1; n=1-30. The present invention further relates to a preparation method of the compound, a pharmaceutical composition taking the compound as an active ingredient, as well as application of the compound in the present invention in antiviral diseases.

Abstract: A bilayer complex proton exchange membrane and a membrane electrode assembly are provided. The bilayer complex proton exchange membrane includes a first complex structure and a second complex structure. The first complex structure includes 0.001-10 wt % of a graphene derivative with two dimension configuration, and 99.999-90 wt % of organic material. The organic material includes polymer material having sulfonic acid group or phosphate group. The second complex structure includes 0.5-30 wt % of inorganic material and 99.5-70 wt % of organic material, wherein a surface area of the inorganic material is 50-3000 m2/g, and the organic material includes polymer material with sulfonic acid group or phosphate group.

Abstract: The present application provides a sublimation ink which is capable of being transferred to natural fiber fabrics, such as cotton and linen, in addition to synthetic fabrics, such as polyester, nylon, etc., and shows significantly improved color fastness. The sublimation ink may include a resin containing at least one active hydrogen, a crosslinking agent having at least two isocyanate (—NCO) groups, and one or more colorants. The sublimation ink may also include one or more carriers, binders, thickeners, and/or solvents. An image can be printed on a transfer medium (e.g. paper) at room temperature with the sublimation ink using conventional offset printer so that the sublimation ink remains inactive. The image can be subsequently transferred onto any desired fabrics under heat and pressure, in which the sublimation ink is activated and bonds the colorant to the fabrics with excellent color effect.

Abstract: The present invention provides 20(R)-ginsenoside Rg3 polyacylated derivatives of the formula (I) and preparation method and anti-tumor application thereof: wherein, R?CH3(CH2)nCO, n=0˜5.

Abstract: The present application provides a sublimation ink which is capable of being transferred to natural fiber fabrics, such as cotton and linen, in addition to synthetic fabrics, such as polyester, nylon, etc., and shows significantly improved color fastness. The sublimation ink may include a resin containing at least one active hydrogen, a crosslinking agent having at least two isocyanate (—NCO) groups, and one or more colorants. The sublimation ink may also include one or more carriers, binders, thickeners, and/or solvents. An image can be printed on a transfer medium (e.g. paper) at room temperature with the sublimation ink using conventional offset printer so that the sublimation ink remains inactive. The image can be subsequently transferred onto any desired fabrics under heat and pressure, in which the sublimation ink is activated and bonds the colorant to the fabrics with excellent color effect.

Abstract: A first communication device receives a first data unit from a second communication device via one or more communication channels. The first data unit includes an indication of a first set of one or more sub-channels allocated to the first communication device, and the first data unit is configured to prompt the first communication device to transmit channel availability information as part of a subsequent orthogonal frequency division multiple access (OFDMA) transmission. The first communication device determines channel availability information for the one or more communication channels, and when the first communication device determines that at least one of the communication channels is idle, the first communication device transmits a second data unit to the second communication device in one or more sub-channels allocated to the first communication device as part of the OFDMA transmission, the second data unit including the channel availability information.

Abstract: A first communication device determines one or more parameters related to a format of a media access control layer (MAC) data unit for an uplink (UL) multi-user (MU) transmission. The format of the MAC data unit for the UL MU transmission is different than a format of a MAC data unit for an UL single user (SU) transmission. The first communication device generates one or more data units that include the one or more parameters. The first communication device transmits the one or more data units to a plurality of second communication devices to inform the plurality of second communication devices of the format of the MAC data unit for UL MU transmissions by the plurality of second communication devices to the first communication device.

Abstract: The present invention relates to a technical field of a tool glove combining with various tools, more particularly to a tool glove applied for construction, civil engineering, outdoor sport, agriculture, forestry, butchery, catering, fishery, husbandry or horticulture. In addition, the tool glove of the present invention can combine with various replaceable toolheads upon working demand, such as building repair, high scaffold assembly/disassembly, hitting work, mountain climbing sport, tree climbing for picking fruit, meat cutting in butchery, peeling and vegetable-fruit cutting in catering, scales removing and fish-shrimp cutting in fishery or husbandry, boring for growing flower in horticulture, earthmoving, painting by using brush or roller in painting works, so that it is not necessary for a user to carry multiple dedicated tools to complete various works.

Abstract: The present invention discloses a new application of a composition of phillyrin and phillygeninin in the preparation of drugs for alleviating or/and treating viral diseases. Experiments prove that the composition of phillyrin and phillygeninin has significant treatment effects on viral influenza and pneumonia, as well as on respiratory syncytial viruses, enteroviruses, herpes zoster simplex viruses, Coxsackie viruses, and the like. This composition is characterized by quick action and less toxic and side effects, and thus is an antiviral drug and health product with safety, high efficiency, stability and simple preparation process, and is suitable for industrial production and easy to promote. The present invention provides a new drug, health product and raw material for preventing and treating various viral diseases.

Abstract: The present invention relates to a chemical synthesis method for phillyrin. The method of the present invention comprises: first dissolving a glycosyl receptor phillygenin and a glycosyl donor in an organic solvent for glycosylation to obtain tetraacyl phillyrin; then dissolving the tetraacyl phillyrin in a second organic solvent, and adding sodium methoxide for deacylation, adding an acidic pH regulator to regulate the pH value of the reaction mixture to neutral; and finally carrying out purification treatment to obtain phillyrin. The advantages and practical values of the chemical synthesis method for phillyrin of the present invention lie in: the raw material is easy to get, the catalysts used for glycosylation are cheap and easy to get, the production cost is greatly reduced, and it can be used for industrial production.

Abstract: The present invention provides a pharmaceutical compound of phillygenin ibuprofen ester as represented by formula (I), preparation method thereof, and applications thereof in anti-virus, antipyresis, anti-inflammation, analgesia and the like: